Assessment of Chronic Lung Allograft Dysfunction Using Single-Breath & Multi-Breath Hyperpolarized Xenon 129 MRI

Assessment of Chronic Lung Allograft Dysfunction Using Single-Breath & Multi-Breath Hyperpolarized Xenon 129 MRI
Recruiting
18 years - 90 years
All
Phase N/A
60 participants needed

Brief description of study

The research study is being conducted to determine the effectiveness of using hyperpolarized xenon-129 (HP 129-Xe) magnetic resonance imaging (MRI) in diagnosing and predicting the clinical course of patients who received lung transplantation. 

Detailed description of study

If you agree to join the study, you will be asked to complete the following research procedures: • Complete a brief MRI safety questionnaire • Practice the breathing procedure that will be performed during the study • MRI scanning using the inhaled MRI contrast agent Hyperpolarized Xenon129 (HP 129Xe) Your participation will last for up to two years. Over the course of your participation, you will be contacted to attend up to five follow up visits after your initial baseline visit. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: pulmonary,lung transplant
  • Age: 18 years - 90 years
  • Gender: All


Updated on 19 Feb 2024. Study ID: 834759

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.